Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

NCT03977480 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped Due to the difficulty to recruit enough patients, the study was terminated.

Conditions

Ulcerative Colitis

Interventions

DRUG: Hemay007
DRUG: Placebo

Sponsor

Tianjin Hemay Pharmaceutical Co., Ltd